BACKGROUND Migrants form a substantial proportion of the population affected by the human immunodeficiency virus (HIV) epidemic in Europe, yet HIV prevention for this population is hindered by poor understanding of access to care and of postmigration transmission dynamics. OBJECTIVE We present the design and methods of the advancing Migrant Access to health Services in Europe (aMASE) study, the first European cross-cultural study focused on multiple migrant populations. It aims to identify the structural, cultural, and financial barriers to HIV prevention, diagnosis, and treatment and to determine the likely country of HIV acquisition in HIV-positive migrant populations. METHODS We delivered 2 cross-sectional electronic surve...
Migrants, defined as individuals who move from their country of origin to another, account for 40% o...
BACKGROUND: The barriers to HIV testing and counselling that migrants encounter can jeopardize proac...
Background: Migration has an impact on the epidemiology of viral hepatitis B and C (HEP) and HIV in ...
INTRODUCTION: Migrants are overrepresented in the European HIV epidemic. We aimed to understand the ...
Improving access to human immunodeficiency virus (HIV) testing and treatment is at the core of a glo...
Migrants are overrepresented in the European HIV epidemic. We aimed to understand the barriers and f...
BACKGROUND: Migrant populations from countries with generalised HIV epidemics make up a significant...
BACKGROUND: In the European Union/European Economic Area (EU/EEA), migrants from high-endemic countr...
Introduction In 2019, the United Nations signalled a substantial rise in the number of international...
<p><b>BACKGROUND: </b>Sub-Saharan African Migrants (SAM) are the second largest gr...
BACKGROUND: In the context of an European Centre for Disease Prevention and Control (ECDC) research ...
Background: Sub-Saharan African Migrants (SAM) are the second largest group affected by HIV/AID...
INTRODUCTION:While sub-Saharan African migrants are the second largest group affected by HIV in Euro...
OBJECTIVE We aimed to estimate the proportion of post-migration HIV acquisition among HIV-positiv...
Objectives: Self-tests are performed and interpreted autonomously by a person without involving a he...
Migrants, defined as individuals who move from their country of origin to another, account for 40% o...
BACKGROUND: The barriers to HIV testing and counselling that migrants encounter can jeopardize proac...
Background: Migration has an impact on the epidemiology of viral hepatitis B and C (HEP) and HIV in ...
INTRODUCTION: Migrants are overrepresented in the European HIV epidemic. We aimed to understand the ...
Improving access to human immunodeficiency virus (HIV) testing and treatment is at the core of a glo...
Migrants are overrepresented in the European HIV epidemic. We aimed to understand the barriers and f...
BACKGROUND: Migrant populations from countries with generalised HIV epidemics make up a significant...
BACKGROUND: In the European Union/European Economic Area (EU/EEA), migrants from high-endemic countr...
Introduction In 2019, the United Nations signalled a substantial rise in the number of international...
<p><b>BACKGROUND: </b>Sub-Saharan African Migrants (SAM) are the second largest gr...
BACKGROUND: In the context of an European Centre for Disease Prevention and Control (ECDC) research ...
Background: Sub-Saharan African Migrants (SAM) are the second largest group affected by HIV/AID...
INTRODUCTION:While sub-Saharan African migrants are the second largest group affected by HIV in Euro...
OBJECTIVE We aimed to estimate the proportion of post-migration HIV acquisition among HIV-positiv...
Objectives: Self-tests are performed and interpreted autonomously by a person without involving a he...
Migrants, defined as individuals who move from their country of origin to another, account for 40% o...
BACKGROUND: The barriers to HIV testing and counselling that migrants encounter can jeopardize proac...
Background: Migration has an impact on the epidemiology of viral hepatitis B and C (HEP) and HIV in ...